Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Management guidelines for non-AIDS morbidity result in increased screening but no change in primary prevention implementation

Trevillyan JM, Dart A, Topliss DJ, Walker RG, Whiting SE, Hoy JF

(2015), AIDS, 29(6), 748-50

Differentiation of Acinetobacter genomic species 13BJ/14TU from Acinetobacter haemolyticus by use of matrix-sssisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS)

Toh BE, Zowawi HM, Krizova L, Paterson DL, Kamolvit W, Peleg AY, Sidjabat H, Nemec A, Pflüger V, Huber CA

(2015), J Clin Microbiol, 53(10), 3384-6

Silent mutations at codons 65 and 66 in reverse transcriptase alleviate indel formation and restore fitness in subtype B HIV-1 containing D67N and K70R drug resistance mutations

Telwatte S, Hearps AC, Johnson A, Latham CF, Moore K, Agius P, Tachedjian M, Sonza S, Sluis-Cremer N, Harrigan PR, Tachedjian G

(2015), Nucleic Acids Res, 43(6), 3256-71

Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome

Tan HY, Yong YK, Andrade BB, Shankar EM, Ponnampalavanar S, Omar SF, Narendran G, Kamarulzaman A, Swaminathan S, Sereti I, Crowe SM, French MA

(2015), AIDS, 29(4), 421-31

Impact of antiretroviral therapy (ART) timing on chronic immune activation/inflammation and end-organ damage

Rajasuriar R, Wright E, Lewin SR

(2015), Curr Opin HIV AIDS, 10(1), 35-42

Glucose metabolism regulates T cell activation, differentiation, and functions

Palmer CS, Ostrowski M, Balderson B, Christian N, Crowe SM

(2015), Front Immunol, 6, 1

Experiences and expectations of participants completing an HIV cure focused clinical trial

McMahon JH, Elliott JH, Roney J, Hagenauer M, Lewin SR

(2015), AIDS, 29(2), 248-50

Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis

Langan KM, Kotsimbos T, Peleg AY

(2015), Curr Opin Infect Dis, 28(6), 547-56

Bone disease in HIV: recommendations for screening and management in the older patient

Hoy J

(2015), Drugs Aging, 32(7), 549-58

Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial

Harris PN, Peleg AY, Iredell J, Ingram PR, Miyakis S, Stewardson AJ, Rogers BA, McBryde ES, Roberts JA, Lipman J, Athan E, Paul SK, Baker P, Harris-Brown T, Paterson DL

(2015), Trials, 16, 24

Factors influencing antiretroviral adherence and virological outcomes in people living with HIV in the highlands of Papua New Guinea

Gare J, Kelly-Hanku A, Ryan CE, David M, Kaima P, Imara U, Lote N, Crowe SM, Hearps AC

(2015), PLoS One, 10(8), e0134918

The influence of bacterial interaction on the virulence of Cryptococcus neoformans

Dhamgaye S, Murray GL, Peleg AY

(2015), Virulence, 6(7), 677-8

Mycobacterium haemophilum bone and joint infection in HIV/AIDS: case report and literature review

Cross GB, Le Q, Webb B, Jenkin GA, Korman TM, Francis M, Woolley I

(2015), Int J STD AIDS, 26(13), 974-81

Surface coatings with covalently attached caspofungin are effective in eliminating fungal pathogens

Coad BR, Lamont-Friedrich SJ, Gwynne L, Jasieniak M, Griesser S, Traven A, Peleg AY, Griesser HJ

(2015), J Mater Chem B, 43(3), 8469-76

Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

Carr A, Grund B, Neuhaus J, Schwartz A, Bernardino JI, White D, Badel-Faesen S, Avihingsanon A, Ensrud K, Hoy J; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group

(2015), HIV Med, 16 Suppl 1, 137-46

Economic comparison of an empirical versus diagnostic-driven strategy for treating invasive fungal disease in immunocompromised patients

Barnes R, Earnshaw S, Herbrecht R, Morrissey O, Slavin M, Bow E, McDade C, Charbonneau C, Weinstein D, Kantecki M, Schlamm H, Maertens J

(2015), Clin Ther, 37(6), 1317-1328.e2

An NK cell population lacking FcRγ is expanded in chronically infected HIV patients

Zhou J, Amran FS, Kramski M, Angelovich TA, Elliott J, Hearps AC, Price P, Jaworowski A

(2015), J Immunol, 194(10), 4688-97

International consensus on allergy immunotherapy

Jutel M, Agache I, Bonini S, Burks AW, Calderon M, Canonica W, Cox L, Demoly P, Frew AJ, O'Hehir R, Kleine-Tebbe J, Muraro A, Lack G, Larenas D, Levin M, Nelson H, Pawankar R, Pfaar O, van Ree R, Sampson H, Santos AF, Du Toit G, Werfel T, Gerth van Wijk R, Zhang L, Akdis CA

(2015), J Allergy Clin Immunol, 136(3), 556-68

The immunoregulatory and fibrotic roles of activin A in allergic asthma

Hardy CL, Rolland JM, O'Hehir RE

(2015), Clin Exp Allergy, 45(10), 1510-22

Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis

Aldunate M, Srbinovski D, Hearps AC, Latham CF, Ramsland PA, Gugasyan R, Cone RA, Tachedjian G

(2015), Front Physiol, 6, 164

318 319 320 321 322